Key points:
1. Poland plans to pass a law in the third quarter of 2025 to completely ban the use of disposable e-cigarettes (whether or not they contain nicotine).
2. The draft emphasizes that testing of e-cigarette liquid ingredients will be authorized, and only products that produce a tobacco flavor will be allowed for sale.
3. The government will restrict the sale of new nicotine products, banning nicotine-containing chewing gum, tablets, and other products, and requiring strict testing and registration.
2Firsts, reporting from Shenzhen - The Polish Ministry of Health is set to draft a legislation that will prohibit the use of disposable e-cigarettes in Poland, regardless of whether they contain nicotine.
The government is planning to pass this law in the third quarter of 2025, as outlined in the Ministerial Council's legislative agenda.
The proposed regulation will further restrict the use of disposable e-cigarettes, not only for those under 18 years old, but even for adult e-cigarette users.
The legislative agenda states that:
"The proposed regulations have the most impact on so-called young people. E-cigarettes, whether they contain nicotine or other substances, are products that pose a clear threat to public health. These products contain highly addictive substances and other accompanying substances, which, when absorbed by the body, have unknown health effects on those who use these products."
The draft legislation will also authorize the director of the Chemical Management Bureau to order testing of e-cigarette liquid ingredients, and to list the names of laboratories responsible for carrying out such tests.
At the same time, in the future only products containing ingredients that produce tobacco scent are allowed to be sold. The government also hopes to limit the market presence of new nicotine products, including so-called "nicotine pouches," through legislation.
In addition, the sale of chewing gum, lozenges, nasal sprays, and beverages containing nicotine is explicitly prohibited. These products must undergo rigorous testing and registration by the pharmaceutical management to confirm their effectiveness and safety.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
